{"slug": "ai-in-drug-r-d-at-last-the-end-of-the-beginning", "title": "AI in Drug R&D: At Last, the End of the Beginning", "summary": "AI is becoming a dominant force in biopharma, with advocates and investors touting it as a transformative technology for drug R&D, while skeptics remain cautious. The discussion marks a shift from abstraction to practical application in the industry.", "body_md": "# AI in Drug R&D: At Last, the End of the Beginning\n\nWith the emergence of AI as an increasingly dominant force in industry (and society), much of the early discussion around AI in biopharma has tended to treat it largely as an abstraction. Advocates and investors insist AI is a transformative superhuman technology poised to domesticate R&D, while cynics, including many grizzled drug hunters, tend to... Read More", "url": "https://wpnews.pro/news/ai-in-drug-r-d-at-last-the-end-of-the-beginning", "canonical_source": "https://www.realclearhealth.com/2026/08/21/ai_in_drug_r_and_d_at_last_the_end_of_the_beginning_1201777.html", "published_at": "2026-08-21 14:38:03+00:00", "updated_at": "2026-08-21 14:45:18.436271+00:00", "lang": "en", "topics": ["artificial-intelligence"], "entities": [], "alternates": {"html": "https://wpnews.pro/news/ai-in-drug-r-d-at-last-the-end-of-the-beginning", "markdown": "https://wpnews.pro/news/ai-in-drug-r-d-at-last-the-end-of-the-beginning.md", "text": "https://wpnews.pro/news/ai-in-drug-r-d-at-last-the-end-of-the-beginning.txt", "jsonld": "https://wpnews.pro/news/ai-in-drug-r-d-at-last-the-end-of-the-beginning.jsonld"}}